Medicare has locked in lower prices on a slate of heavily used prescription drugs, a shift that will ripple through household budgets, federal spending and the broader drug market over the next few ...

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...

The federal government has announcedthe results of the latest round of Medicare drug price negotiations: 15 lower drug prices for Medicare to go into effect in 2027. Medicare will get a 71% discount ...

With Johnson & Johnson’s participation, 15 of 17 companies contacted by the administration over the summer have now signed on. Earlier deals had been announced with Pfizer, AstraZeneca, EMD Serono, ...

Incoming PhRMA Chair Paul Hudson, a day before the White House announcement, pledged to work with the administration as the ...

The Trump administration has negotiated lower prices for 15 widely used medications covered by Medicare, with the federal government saying the effort will cut spending on those drugs by 44%, or about ...

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. In their words: An examination of statements Trump officials ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Pharmaceutical companies Amgen, Bristol Myers Squibb, Boehringer ...